Dimensional Fund Advisors’s ChemoCentryx, Inc. CCXI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-100,626
Closed -$5.2M 3555
2022
Q3
$5.2M Sell
100,626
-94,862
-49% -$3.92M ﹤0.01% 2414
2022
Q2
$4.84M Sell
195,488
-124,852
-39% -$2.75M ﹤0.01% 2457
2022
Q1
$8.03M Buy
320,340
+172,958
+117% +$4.86M ﹤0.01% 2380
2021
Q4
$5.37M Buy
147,382
+2,718
+2% +$95.4K ﹤0.01% 2541
2021
Q3
$2.47M Buy
144,664
+9,672
+7% +$151K ﹤0.01% 2791
2021
Q2
$1.81M Sell
134,992
-2,130
-2% -$52.5K ﹤0.01% 2895
2021
Q1
$7.03M Sell
137,122
-158,760
-54% -$9.55M ﹤0.01% 2451
2020
Q4
$18.3M Sell
295,882
-305,656
-51% -$17.5M 0.01% 2020
2020
Q3
$33M Sell
601,538
-317,642
-35% -$17.1M 0.01% 1529
2020
Q2
$52.9M Sell
919,180
-6,744
-0.7% -$367K 0.02% 1154
2020
Q1
$37.2M Sell
925,924
-46,386
-5% -$1.97M 0.02% 1295
2019
Q4
$38.5M Sell
972,310
-63,084
-6% -$1.11M 0.01% 1659
2019
Q3
$7.02M Hold
1,035,394
﹤0.01% 2484
2019
Q2
$9.63M Sell
1,035,394
-159,596
-13% -$1.85M ﹤0.01% 2408
2019
Q1
$16.6M Buy
1,194,990
+562,929
+89% +$6.44M 0.01% 2151
2018
Q4
$6.9M Buy
632,061
+84,290
+15% +$889K ﹤0.01% 2496
2018
Q3
$6.92M Buy
547,771
+226,485
+70% +$2.73M ﹤0.01% 2579
2018
Q2
$4.23M Buy
+321,286
New +$3.84M ﹤0.01% 2704
2015
Q1
Sell
-9,699
Closed -$66K 3411
2014
Q4
$66K Buy
9,699
+2,200
+29% +$11.6K ﹤0.01% 3354
2014
Q3
$34K Hold
7,499
﹤0.01% 3422
2014
Q2
$44K Hold
7,499
﹤0.01% 3447
2014
Q1
$50K Sell
7,499
-7,562
-50% -$52.5K ﹤0.01% 3450
2013
Q4
$87K Buy
+15,061
New +$77.7K ﹤0.01% 3366

Other funds holding CCXI

Dimensional Fund Advisors's CCXI Position: Q4 2022 in Review

Dimensional Fund Advisors sold out of ChemoCentryx, Inc. (CCXI) in Q4 2022, closing a stake of 100,626 shares — an estimated $5.2M sold.

Dimensional Fund Advisors first reported a position in CCXI in Q4 2013 and held it in 23 quarters. The position peaked at $52.9M in Q2 2020. 1 fund tracked by Wall St. Rank holds CCXI as of Q4 2022.

  • Dimensional Fund Advisors reported no remaining ChemoCentryx, Inc. position as of Q4 2022 after selling out during the quarter.
  • Dimensional Fund Advisors sold 100,626 ChemoCentryx, Inc. shares in Q4 2022, an estimated $5.2M.
  • Dimensional Fund Advisors first reported a position in ChemoCentryx, Inc. in Q4 2013 and held it in 23 quarters.
  • Dimensional Fund Advisors's ChemoCentryx, Inc. position peaked at $52.9M in Q2 2020.
  • 1 fund tracked by Wall St. Rank held ChemoCentryx, Inc. as of Q4 2022.

Based on Dimensional Fund Advisors's 13F filing for Q4 2022, filed 9 Feb 2023.